Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    62,517.67
    -1,577.45 (-2.46%)
     

  • CMC Crypto 200

    1,316.32
    -80.21 (-5.74%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • Dow

    38,239.66
    +153.86 (+0.40%)
     

  • Nasdaq

    15,927.90
    +316.14 (+2.03%)
     

  • Gold

    2,349.60
    +7.10 (+0.30%)
     

  • Crude Oil

    83.66
    +0.09 (+0.11%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

New Strong Sell Stocks for February 16th

Zacks Equity Research
Updated
Wall Street finished in the green reversing its five-day negative trend on Thursday following news that United States and China have ramped up their efforts to resolve lingering trade disputes

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Ventas, Inc. VTR is the owner and operator of a real estate investment trust. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 30 days.

Stepan Company SCL is a producer and seller of specialty and intermediate chemicals. The Zacks Consensus Estimate for its current year earnings has been revised 0.7% downward over the last 30 days.

Motorcar Parts of America, Inc. MPAA is the manufacturer and distributor of automotive aftermarket parts. The Zacks Consensus Estimate for its current year earnings has been revised 12.6% downward over the last 60 days.

ADVERTISEMENT

Great Plains Energy Incorporated GXP is a generator and distributor of electricity. The Zacks Consensus Estimate for its current year earnings has been revised 1.2% downward over the last 60 days.

Galapagos NV GLPG is develops and commercializes novel medicines. The Zacks Consensus Estimate for its current year earnings has been revised 2.3% downward over the last 60 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Great Plains Energy Inc (GXP) : Free Stock Analysis Report
 
Motorcar Parts of America, Inc. (MPAA) : Free Stock Analysis Report
 
Stepan Company (SCL) : Free Stock Analysis Report
 
Galapagos NV (GLPG) : Free Stock Analysis Report
 
Ventas, Inc. (VTR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research